Stockscreener 앱 받기
2.715
1.09%
-0.03
시장 영업 전:
2.55
-0.165
-6.08%
Eledon Pharmaceuticals Inc 주식(ELDN)의 최신 뉴스
Detecting support and resistance levels for Eledon Pharmaceuticals Inc.Free Oversold Bounce Stock Play Ideas - Newser
Why Eledon Pharmaceuticals Inc. is moving todayFree Short Term High Yield Stock Tips - Newser
How to recover losses in Eledon Pharmaceuticals Inc. stockStock Performance Summary Over One Year - Newser
Can trapped investors hope for a rebound in Eledon Pharmaceuticals Inc.Stock Entry Points Based on Technicals - Newser
Can Eledon Pharmaceuticals Inc. rally from current levelsRisk-Managed Trade Alerts for Consistency - Newser
Statistical indicators supporting Eledon Pharmaceuticals Inc.’s strengthRisk Shielded Trade Watch with Analysis - Newser
Can Eledon Pharmaceuticals Inc. hit a new high this monthMulti-Year Signal Summary and Entry Timing - Newser
Using Bollinger Bands to evaluate Eledon Pharmaceuticals Inc.Bear Market Safe Zone Technical Analysis - Newser
Has Eledon Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility ReviewFree Trade Timing Strategy With Technical Data - Newser
Is Eledon Pharmaceuticals Inc. stock a good hedge against inflationTrade Plan With Low Risk High Return - Newser
Volatility clustering patterns for Eledon Pharmaceuticals Inc.Free High Return Stock Focus With Safety - Newser
Should you hold or exit Eledon Pharmaceuticals Inc. nowFree Access to Real-Time Trade Insights - Newser
Using portfolio simulators with Eledon Pharmaceuticals Inc. includedEarly Entry Ideas with Momentum Potential - Newser
Order flow analysis tools used on Eledon Pharmaceuticals Inc.Watchlist Generator With Real-Time Entry - Newser
Eledon Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveWeekly Chart-Based Forecast for Traders - Newser
Eledon Pharmaceuticals Inc. stock outlook for YEARBuy and Hold Position Summary Review - Newser
What makes Eledon Pharmaceuticals Inc. stock price move sharplyWatchlist Generator for Smart Money Signals - Newser
Ipsen is no longer advancing Sutro’s ADC; Layoffs at Tune Therapeutics - Endpoints News
Custom watchlist performance reports with Eledon Pharmaceuticals Inc.Free Reliable Alerts for Daily Stock Movers - Newser
Eledon Pharmaceuticals shares rise 2.37% after-hours following updated Phase Ib data conference call. - AInvest
Mixed market reaction to Eledon Phase Ib trial for tegoprubart - The Pharma Letter
Eledon Plunges 17.15% on Clinical Trial Data, Oracle Rumors - AInvest
Promising Phase 1b Results of Tegoprubart Support Buy Rating for Eledon Pharmaceuticals - TipRanks
Eledon Pharmaceuticals shares fall 9.88% premarket despite positive Phase 1b trial data for tegoprubart. - AInvest
Real time alert setup for Eledon Pharmaceuticals Inc. performancePredictable Income Summary for Long-Term Trades - Newser
Eledon Pharmaceuticals Reports Promising Phase 1b Trial Results - TipRanks
Eledon Presents Updated Data from Ongoing Phase 1b Trial - GlobeNewswire
New Kidney Transplant Drug Outperforms Standard Treatment: 68 vs 53 eGFR Score in Phase 1b Trial - Stock Titan
Global Renal Transplant Therapeutics Market is Expected to Cross ~USD 18 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
How Eledon Pharmaceuticals Inc. stock performs during market volatilityDaily Profit Watch With Forecast Confidence - Newser
Does Eledon Pharmaceuticals Inc. qualify in momentum factor screeningFree Growth Based Investment Plan Guidance - Newser
Combining price and volume data for Eledon Pharmaceuticals Inc.Chart Risk Profile for Capital Preservation - Newser
What institutional investors are buying Eledon Pharmaceuticals Inc. stockTriple-digit return opportunities - Jammu Links News
Eledon Pharmaceuticals Inc. Stock Analysis and ForecastFree Consultation - Jammu Links News
Does Eledon Pharmaceuticals Inc. stock perform well during market downturnsBuild a portfolio with strong long-term growth - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):